Volume 12 Issue 4
Jul.  2021
Turn off MathJax
Article Contents
Zheng Shanshan, Liu Sheng, Tang Hanwei, et al. Early outcomes of heart transplantation in critical patients: single center experience of Fuwai Hospital[J]. ORGAN TRANSPLANTATION, 2021, 12(4): 450-457. doi: 10.3969/j.issn.1674-7445.2021.04.012
Citation: Zheng Shanshan, Liu Sheng, Tang Hanwei, et al. Early outcomes of heart transplantation in critical patients: single center experience of Fuwai Hospital[J]. ORGAN TRANSPLANTATION, 2021, 12(4): 450-457. doi: 10.3969/j.issn.1674-7445.2021.04.012

Early outcomes of heart transplantation in critical patients: single center experience of Fuwai Hospital

doi: 10.3969/j.issn.1674-7445.2021.04.012
More Information
  • Corresponding author: Zheng Zhe, Email: zhengzhe@fuwai.com
  • Received Date: 2021-04-08
    Available Online: 2021-07-13
  • Publish Date: 2021-07-15
  •   Objective  To analyze the early outcomes of heart transplantation in critical patients and its significance in donor allocation decision.  Methods  Clinical data of 449 recipients undergoing heart transplantation were retrospectively analyzed. According to preoperative status, all patients were divided into the critical status group (n=64) and general status group (n=385). The incidence of critical status was summarized. Clinical data of recipients were statistically compared between two groups. Postoperative survival and causes of death in recipients between two groups were analyzed. Perioperative results of critical recipients undergoing different mechanical circulation support as a bridge to heart transplantation were compared.  Results  Critical patients accounted for 14.3% of the total number of transplant recipients. The proportion of critical patients gradually increased in recent 5 years. Compared with the general status group, the recipients in critical status group had a lower proportion of smoking history, a higher proportion of cardiac surgery history, a higher serum level of creatinine, and a higher proportion of primary diseases of heart failure before heart transplantation(all P≤0.01). The proportion of undergoing mechanical circulation support was higher, the incidence of complications was higher, the stay time in intensive care unit (ICU) was longer and the in-hospital fatality was higher after heart transplantation in the critical status group (all P≤0.01). The 1-year survival rate of recipients in critical status group was significantly lower than that in general status group (83% vs. 95%, P < 0.01). The fatality of recipients due to infection and multiple organ failure in critical status group was higher than that in general status group. Among 64 critical recipients, 1 recipient received ventilator alone, and 63 recipients underwent mechanical circulation support devices as a bridge to heart transplantation. Among them, intra-aortic balloon pump (IABP) alone was applied in 49 cases (77%), 8 cases (13%) of extracorporeal membrane oxygenation (ECMO) combined with IABP, 4 cases (6%) of ECMO alone, and 2 cases (3%) of left ventricular assist device (LVAD) alone. Critical patients who received preoperative ECMO and ECMO combined with IABP bridging to heart transplantation have a higher proportion of postoperative complications, a longer ICU stay time, a longer mechanical ventilation time, and a higher proportion of hospital deaths.  Conclusions  The overall prognosis of critical patients undergoing heart transplantation is relatively poor. Effective preoperative management may reverse the high-risk status of critical patients in a certain extent. The limited quantity of donor heart should be allocated to the most urgent patients who can obtain the greatest benefit from heart transplantation.

     

  • loading
  • [1]
    CRESPO-LEIRO MG, METRA M, LUND LH, et al. Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology[J]. Eur J Heart Fail, 2018, 20(11): 1505-1535. DOI: 10.1002/ejhf.1236.
    [2]
    韩宗茂, 高洁, 高传玉, 等. 晚期心力衰竭的治疗现状及研究进展[J]. 中华实用诊断与治疗杂志, 2020, 34(12): 1290-1293. DOI: 10.13507/j.issn.1674-3474.2020.12.026.

    HAN ZM, GAO J, GAO CY, et al. Current status of treatment and research progress of advanced heart failure[J]. J Chin Pract Diagn Ther, 2020, 34(12): 1290-1293. DOI: 10.13507/j.issn.1674-3474.2020.12.026.
    [3]
    HOOSAIN J, HANKINS S. Time is a precious commodity: 2018 OPTN policy change and the potential to lower heart transplant waitlist time in the sickest patients[J]. Curr Cardiol Rep, 2019, 21(7): 67. DOI: 10.1007/s11886-019-1150-8.
    [4]
    STEVENSON LW. Crisis awaiting heart transplantation: sinking the lifeboat[J]. JAMA Intern Med, 2015, 175(8): 1406-1409. DOI: 10.1001/jamainternmed.2015.2203.
    [5]
    COWGER JA. Addressing the growing U.S. donor heart shortage: waiting for godot or a transplant?[J]. J Am Coll Cardiol, 2017, 69(13): 1715-1717. DOI: 10.1016/j.jacc.2017.02.010.
    [6]
    KHUSH KK, POTENA L, CHERIKH WS, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 37th adult heart transplantation report-2020; focus on deceased donor characteristics[J]. J Heart LungTransplant, 2020, 39(10): 1003-1015. DOI: 10.1016/j.healun.2020.07.010.
    [7]
    KHUSH KK, CHERIKH WS, CHAMBERS DC, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-sixth adult heart transplantation report - 2019; focus theme: donor and recipient size match[J]. J Heart Lung Transplant, 2019, 38(10): 1056-1066. DOI: 10.1016/j.healun.2019.08.004.
    [8]
    REICH H, RAMZY D, MORIGUCHI J, et al. Acceptable post-heart transplant outcomes support temporary MCS prioritization in the new OPTN|UNOS heart allocation policy[J]. Transplant Proc, 2021, 53(1): 353-357. DOI: 10.1016/j.transproceed.2020.04.1819.
    [9]
    RUSHTON S, PARAMESHWAR J, LIM S, et al. The introduction of a super-urgent heart allocation scheme in the UK: a 2-year review[J]. J Heart Lung Transplant, 2020, 39(10): 1109-1117. DOI: 10.1016/j.healun.2020.06.013.
    [10]
    VIEIRA JL, VENTURA HO, MEHRA MR. Mechanical circulatory support devices in advanced heart failure: 2020 and beyond[J]. Prog Cardiovasc Dis, 2020, 63(5): 630-639. DOI: 10.1016/j.pcad.2020.09.003.
    [11]
    SÁNCHEZ-ENRIQUE C, JORDE UP, GONZÁLEZ-COSTELLO J. Heart transplant and mechanical circulatory support in patients with advanced heart failure[J]. Rev Esp Cardiol (Engl Ed), 2017, 70(5): 371-381. DOI: 10.1016/j.rec.2016.12.036.
    [12]
    GAMBINO A. Challenges in heart transplantation: now and the future[J]. Transplant Proc, 2003, 35(8): 3069-3071. DOI: 10.1016/j.transproceed.2003.10.041.
    [13]
    PRIETO D, CORREIA P, ANTUNES P, et al. Results of heart transplantation in the urgent recipient-who should be transplanted?[J] Rev Bras Cir Cardiovasc, 2014, 29(3): 379-387. DOI: 10.5935/1678-9741.20140072.
    [14]
    国家卫生健康委员会. 关于印发中国人体器官分配与共享基本原则和核心政策的通知[EB/OL]. [2021-03-31]. http://www.nhc.gov.cn/yzygj/s3586/201808/d35d96f2db82403ebe2ba41f2c583896.shtml.
    [15]
    GOFF RR, UCCELLINI K, LINDBLAD K, et al. A change of heart: preliminary results of the US 2018 adult heart allocation revision[J]. Am J Transplant, 2020, 20(10): 2781-2790. DOI: 10.1111/ajt.16010.
    [16]
    TRIVEDI JR, CHENG A, ISING M, et al. Heart transplant survival based on recipient and donor risk scoring: a UNOS database analysis[J]. ASAIO J, 2016, 62(3): 297-301. DOI: 10.1097/MAT.0000000000000337.
    [17]
    JOYCE DL, LI Z, EDWARDS LB, et al. Predicting 1-year cardiac transplantation survival using a donor-recipient risk-assessment tool[J]. J Thorac Cardiovasc Surg, 2018, 155(4): 1580-1590. DOI: 10.1016/j.jtcvs.2017.10.079.
    [18]
    OUYANG D, GULATI G, HA R, et al. Incidence of temporary mechanical circulatory support before heart transplantation and impact on post-transplant outcomes[J]. J Heart Lung Transplant, 2018, 37(9): 1060-1066. DOI: 10.1016/j.healun.2018.04.008.
    [19]
    YIN MY, WEVER-PINZON O, MEHRA MR, et al. Post-transplant outcome in patients bridged to transplant with temporary mechanical circulatory support devices[J]. J Heart Lung Transplant, 2019, 38(8): 858-869. DOI: 10.1016/j.healun.2019.04.003.
    [20]
    STERN LK, VELLECA A, NISHIHARA K, et al. Impact of the United Network for organ sharing 2018 donor heart allocation system on transplant morbidity and mortality[J]. Clin Transplant, 2021, 35(2): e14181. DOI: 10.1111/ctr.14181.
    [21]
    JASSERON C, LEGEAI C, JACQUELINET C, et al. Optimization of heart allocation: the transplant risk score[J]. Am J Transplant, 2019, 19(5): 1507-1517. DOI: 10.1111/ajt.15201.
    [22]
    HASANKHANI F, KHADEMI A. Efficient and fair heart allocation policies for transplantation[J]. MDM Policy Pract, 2017, 2(1): 1-12. DOI: 10.1177/2381468317709475.
    [23]
    SHAH KS, KITTLESON MM, KOBASHIGAWA JA. Updates on heart transplantation[J]. Curr Heart Fail Rep, 2019, 16(5): 150-156. DOI: 10.1007/s11897-019-00432-3.
    [24]
    MERLO A, BHATIA M. Pro: the new heart allocation system is a positive change in the listing of patients awaiting transplant[J]. J Cardiothorac Vasc Anesth, 2020, 34(7): 1962-1967. DOI: 10.1053/j.jvca.2020.02.042.
    [25]
    JIMENEZ J, BENNETT EDWARDS L, HIGGINS R, et al. Should stable UNOS status 2 patients be transplanted?[J]. J Heart Lung Transplant, 2005, 24(2): 178-183. DOI: 10.1016/j.healun.2003.10.019.
    [26]
    MOKADAM NA, EWALD GA, DAMIANO RJ JR, et al. Deterioration and mortality among patients with United Network for Organ Sharing status 2 heart disease: caution must be exercised in diverting organs[J]. J Thorac Cardiovasc Surg, 2006, 131(4): 925-926. DOI: 10.1016/j.jtcvs.2005.08.022.
    [27]
    LIETZ K, MILLER LW. Improved survival of patients with end-stage heart failure listed for heart transplantation: analysis of organ procurement and transplantation network/U.S. United Network of Organ Sharing data, 1990 to 2005[J]. J Am Coll Cardiol, 2007, 50(13): 1282-1290. DOI: 10.1016/j.jacc.2007.04.099.
    [28]
    TAYLOR LJ, FIEDLER AG. Balancing supply and demand: review of the 2018 donor heart allocation policy[J]. J Card Surg, 2020, 35(7): 1583-1588. DOI: 10.1111/jocs.14609.
    [29]
    CAI AW, ISLAM S, HANKINS SR, et al. Mechanical circulatory support in the treatment of advanced heart failure[J]. Am J Transplant, 2017, 17(12): 3020-3032. DOI: 10.1111/ajt.14403.
    [30]
    LOFORTE A, GLIOZZI G, MARIANI C, et al. Ventricular assist devices implantation: surgical assessment and technical strategies[J]. Cardiovasc Diagn Ther, 2021, 11(1): 277-291. DOI: 10.21037/cdt-20-325.
    [31]
    SPILIOPOULOS S, KOERFER R, TENDERICH G. Early outcomes with marginal donor hearts compared with left ventricular assist device support in patients with advanced heart failure: could the cardiac allocation score be the solution to the dilemma of therapy selection?[J] Ann Thorac Surg, 2016, 101(4): 1630. DOI: 10.1016/j.athoracsur.2015.08.082.
    [32]
    吕鹏飞, 刘盛. 连续血流左心室辅助装置的发展现状[J]. 临床和实验医学杂志, 2019, 18(8): 894-897. DOI: 10.3969/j.issn.1671-4695.2019.08.033.

    LYU PF, LIU S. Development status of continuous blood flow left ventricular assist device[J]. J Clin Exp Med, 2019, 18(8): 894-897. DOI: 10.3969/j.issn.1671-4695.2019.08.033.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(3)  / Tables(2)

    Article Metrics

    Article views (858) PDF downloads(68) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return